Celldex Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 8.56 M | $271.54 M | 5.95% | 12.87% |
| KYNAM CAPITAL MANAGEMENT, LP | 05/15/2026 | 5.84 M | $185.26 M | -1.73% | 8.78% |
| BLACKROCK, INC. | 05/13/2026 | 5.37 M | $170.33 M | -1.50% | 8.08% |
| FMR LLC | 05/15/2026 | 3.75 M | $118.92 M | -23.61% | 5.64% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 3.23 M | $102.45 M | 83.69% | 4.86% |
| 05/15/2026 | 2.96 M | $93.92 M | 100.00% | 4.45% | |
| STATE STREET CORP | 05/15/2026 | 2.80 M | $88.95 M | -17.47% | 4.22% |
| COMMODORE CAPITAL LP | 05/15/2026 | 2.70 M | $85.54 M | 5.13% | 4.06% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 2.09 M | $66.18 M | 2.29% | 3.14% |
| EVERSEPT PARTNERS, LP | 05/15/2026 | 1.79 M | $56.72 M | 24.62% | 2.69% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.69 M | $53.56 M | 3.72% | 2.54% |
| BRAIDWELL LP | 05/15/2026 | 1.36 M | $43.01 M | -27.02% | 2.04% |
| DEEP TRACK CAPITAL, LP | 05/15/2026 | 1.28 M | $40.73 M | -32.45% | 1.93% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 1.25 M | $39.76 M | 3.37% | 1.89% |
| VESTAL POINT CAPITAL, LP | 05/15/2026 | 1.22 M | $38.83 M | 5.08% | 1.84% |
| NOVO HOLDINGS A/S | 05/15/2026 | 1.20 M | $38.06 M | 0.00% | 1.80% |
| BELLEVUE GROUP AG | 05/15/2026 | 1.20 M | $38.06 M | -66.83% | 1.80% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 1.06 M | $33.60 M | 62.58% | 1.59% |
| EVENTIDE ASSET MANAGEMENT, LLC | 05/15/2026 | 1.04 M | $32.89 M | -36.87% | 1.56% |
| FISHER ASSET MANAGEMENT, LLC | 05/05/2026 | 1.01 M | $32.15 M | 8.16% | 1.52% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 988.42 K | $31.35 M | -7.46% | 1.49% |
| PICTET ASSET MANAGEMENT HOLDING SA | 04/22/2026 | 923.70 K | $29.30 M | -4.64% | 1.39% |
| 05/15/2026 | 865.00 K | $27.44 M | 0.00% | 1.30% | |
| AMERICAN CENTURY COMPANIES INC | 05/15/2026 | 856.31 K | $27.16 M | 0.13% | 1.29% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 708.65 K | $22.48 M | 70.80% | 1.07% |
| BAKER BROS. ADVISORS LP | 05/15/2026 | 665.37 K | $21.11 M | 0.00% | 1.00% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2026 | 650.27 K | $20.63 M | -6.10% | 0.98% |
| 05/08/2026 | 629.25 K | $19.96 M | 100.00% | 0.95% | |
| NORTHERN TRUST CORP | 05/14/2026 | 577.27 K | $18.31 M | 4.96% | 0.87% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 545.49 K | $17.30 M | -0.95% | 0.82% |
| WOODLINE PARTNERS LP | 05/15/2026 | 500.13 K | $15.86 M | 0.00% | 0.75% |
| AFFINITY ASSET ADVISORS, LLC | 05/14/2026 | 500.00 K | $15.86 M | 42.86% | 0.75% |
| 5AM VENTURE MANAGEMENT, LLC | 05/15/2026 | 497.27 K | $15.77 M | 0.00% | 0.75% |
| IKARIAN CAPITAL, LLC | 05/15/2026 | 461.25 K | $14.63 M | 100.00% | 0.69% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 450.00 K | $14.27 M | 28.57% | 0.68% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 429.60 K | $13.63 M | 100.00% | 0.65% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 427.82 K | $13.57 M | -33.85% | 0.64% |
| TSP CAPITAL MANAGEMENT GROUP, LLC | 04/24/2026 | 375.13 K | $11.90 M | 0.00% | 0.56% |
| KENNEDY CAPITAL MANAGEMENT LLC | 05/13/2026 | 352.30 K | $11.18 M | 100.00% | 0.53% |
| SEGALL BRYANT & HAMILL, LLC | 05/22/2026 | 346.92 K | $11.00 M | -32.58% | 0.52% |
| ROSALIND ADVISORS, INC. | 05/14/2026 | 330.00 K | $10.47 M | 100.00% | 0.50% |
| PFM HEALTH SCIENCES, LP | 05/15/2026 | 324.96 K | $10.31 M | 144.03% | 0.49% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 05/15/2026 | 315.91 K | $10.02 M | 100.00% | 0.48% |
| TFG ASSET MANAGEMENT GP LTD | 05/15/2026 | 312.32 K | $9.91 M | 28.10% | 0.47% |
| UBS GROUP AG | 05/05/2026 | 296.97 K | $9.42 M | -9.03% | 0.45% |
| PALO ALTO INVESTORS LP | 05/15/2026 | 296.41 K | $9.40 M | 100.00% | 0.45% |
| CANDRIAM S.C.A. | 04/30/2026 | 278.89 K | $8.85 M | 100.00% | 0.42% |
| REDMILE GROUP, LLC | 05/15/2026 | 261.51 K | $8.30 M | -7.69% | 0.39% |
| STEMPOINT CAPITAL LP | 05/18/2026 | 254.27 K | $8.07 M | 100.00% | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 05/15/2026 | 243.58 K | $7.73 M | 1.59% | 0.37% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Celldex Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 263 institutional investors and hedge funds held shares of Celldex Therapeutics Inc.. The most heavily invested institutionals were:
WELLINGTON MANAGEMENT GROUP LLP: 8.56 M
Kynam Capital Management, LP: 5.84 M
BlackRock, Inc.: 5.37 M
FMR LLC: 3.75 M
Point72 Asset Management, L.P.: 3.23 M
STATE STREET CORP: 2.8 M
109.69% of Celldex Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 80.68 M shares in the last 24 months. This purchase volume represents approximately $2.48 B in transactions.